Page last updated: 2024-11-01

nifedipine and Cerebrovascular Moyamoya Disease

nifedipine has been researched along with Cerebrovascular Moyamoya Disease in 2 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Research Excerpts

ExcerptRelevanceReference
"Moyamoya disease is a progressive disease which involves the internal carotid arteries and its branches bilaterally."1.29Twins with moyamoya disease. ( Mehmet, K; Nilgün, Y; Sabahattin, K; Sarenur, T; Tugrul, O; Vesile, O; Yusuf, D, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sarenur, T1
Mehmet, K1
Vesile, O1
Nilgün, Y1
Yusuf, D1
Sabahattin, K1
Tugrul, O1
Takagi, Y1
Hashimoto, N1
Goto, Y1

Other Studies

2 other studies available for nifedipine and Cerebrovascular Moyamoya Disease

ArticleYear
Twins with moyamoya disease.
    Acta paediatrica Japonica : Overseas edition, 1994, Volume: 36, Issue:6

    Topics: Carotid Artery, Internal; Child, Preschool; Diseases in Twins; Female; Haplotypes; HLA Antigens; Hum

1994
Haemodynamic ischaemia in paediatric moyamoya disease associated with renovascular hypertension.
    Acta neurochirurgica, 1997, Volume: 139, Issue:3

    Topics: Antihypertensive Agents; Brain; Cerebral Angiography; Cerebral Cortex; Cerebral Infarction; Cerebral

1997